CRVS Stock Analysis: Buy, Sell, or Hold?
CRVS - Corvus Pharmaceuticals, Inc.
$15.62
-0.30 (-1.88%)
▼
5d:
-8.87%
30d:
+11.49%
90d:
-29.26%
HOLD
LOW Confidence
Analysis Updated: Apr 28, 2026 12:00 AM ET
Earnings: May 14, 2026
14d
Smart Money Accumulation
CRVS is down 8.5% this week, but smart money is accumulating calls. Top strike: $19 2026-06-18 with 445 OI. Call ratio: 100% View Scanner →
Strength: 9.3/10
Get Alerted When CRVS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: CRVS shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: CRVS shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: CRVS is currently trading at $15.62, which is considered extended relative to its 30-day fair value range of $13.86 to $16.05.
Technical Outlook: Technically, CRVS is in a uptrend. Immediate support is located at $14.38, while resistance sits at $19.70.
Market Sentiment: CRVS has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $33.33 (+113.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, CRVS is in a uptrend. Immediate support is located at $14.38, while resistance sits at $19.70.
Market Sentiment: CRVS has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $33.33 (+113.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$13.86 -
$16.05
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
63.2%
Protect Your Profits
Holding CRVS? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 113.4% below Wall St target ($33.33)
- CAUTION: Recommendation downgraded due to -8.9% 5-day decline
Trading Range Analysis
30-Day Trading Range
$13.86 -
$16.05
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$14.38
Resistance Level
$19.70
Current Trend
Uptrend
Technical data as of
Apr 28, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-21.49
Wall Street Target
$33.33
(+113.4%)
Share & Embed Analysis
Last updated: April 29, 2026 4:26 AM ET
Data refreshes hourly during market hours. Next update: 5:26 AM
Data refreshes hourly during market hours. Next update: 5:26 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CRVS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
33 analysts |
$449 | 52 HOLD |
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$22 | 54 HOLD |
|
INSM
Insmed Inc |
STRONG BUY
19 analysts |
$213 | 60 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$36 | 57 HOLD |
|
ACAD
ACADIA Pharmaceuticals I… |
BUY
20 analysts |
$32 | 67 BUY |
Advanced CRVS Option Strategies
Professional options setups generated by AI based on today's CRVS price and gamma walls.
